Article info
PDFOrphan lung disease
Original Article
Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study
- Correspondence to Professor Simon R Johnson, Division of Respiratory Medicine, University of Nottingham, Respiratory Medicine, Queens Medical Centre, Nottingham NG7 2UH, UK; simon.johnson{at}nottingham.ac.uk
Citation
Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study
Publication history
- Received August 7, 2017
- Revised September 19, 2017
- Accepted October 2, 2017
- First published October 9, 2017.
Online issue publication
September 01, 2022
Article Versions
- Previous version (20 March 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.